| P2093 | author name string | Siraj Ahmed Khan | |
| | Shaik Mohammad Naushad | |
| | Iyyapu Krishna Mohan | |
| | M Vijaya Bhaskar | |
| | Jyothirmayi Kanukurti | |
| | K S S Sai Baba | |
| | N N Sreedevi | |
| | Noorjahan Mohammed | |
| | O Sai Satish | |
| P2860 | cites work | The Role of Galectin-3 in the Kidneys | Q26752754 |
| | Biomarkers in heart failure | Q28280109 |
| | Short- and Long-term Biologic Variability of Galectin-3 and Other Cardiac Biomarkers in Patients with Stable Heart Failure and Healthy Adults. | Q50961741 |
| | Predictive value of plasma galectin-3 in patients with chronic heart failure. | Q51005416 |
| | Diagnostic significance of serum galectin-3 levels in heart failure with preserved ejection fraction. | Q52139416 |
| | Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association | Q57629814 |
| | Within-day variation and influence of physical exercise on circulating Galectin-3 in patients with rheumatoid arthritis and healthy individuals | Q57832125 |
| | Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study | Q89027396 |
| | Galectin-3 and Arterial Stiffness in Patients with Heart Failure: A Pilot Study | Q89399165 |
| | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases | Q90073141 |
| | Galectin-3 Is a Potential Mediator for Atherosclerosis | Q90152813 |
| | Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study | Q91895158 |
| | The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. | Q30358659 |
| | Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study | Q33529398 |
| | Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure | Q34032111 |
| | Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis | Q34316944 |
| | Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction | Q34528187 |
| | The regulation of inflammation by galectin-3. | Q34991925 |
| | Galectin-3: a novel mediator of heart failure development and progression | Q34995162 |
| | The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities | Q35109687 |
| | Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure. | Q36522700 |
| | Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study | Q36693904 |
| | Emerging biomarkers in heart failure | Q37956614 |
| | The pleiotropic effects of galectin-3 in neuroinflammation: a review | Q38073036 |
| | Galectin-3 in heart failure with preserved ejection fraction | Q38104695 |
| | Galectin-3 in autoimmunity and autoimmune diseases | Q38542678 |
| | The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management | Q38551693 |
| | Comparative study of galectin-3 and B-type natriuretic peptide as biomarkers for the diagnosis of heart failure | Q38687046 |
| | Galectin-3 in heart failure: more answers or more questions? | Q42635235 |
| | Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study | Q43598066 |
| | Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals | Q47355354 |
| | Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update | Q47653100 |
| | Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices | Q47682346 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | ejection fraction | Q641303 |
| | biomarker | Q864574 |
| | Heart failure with preserved ejection fraction | Q3799239 |
| P304 | page(s) | 126-132 | |
| P577 | publication date | 2020-08-01 | |
| P1433 | published in | Journal of Laboratory Physicians | Q15817090 |
| P1476 | title | Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction | |
| P478 | volume | 12 | |